Redefining the R1 resection for pancreatic ductal adenocarcinoma: Tumour lymph nodal burden and lymph node ratio are the only prognostic factors associated with survival

HPB

Volumn 15, Issue 9, 2013, Pages 674-680

  John, Biku J ^a   Naik, Prashant ^a   Ironside, Alastair ^b   Davidson, Brian R ^a   Fusai, Guiseppe ^a   Gillmore, Roopinder ^b   Watkins, Jennifer ^b   Rahman, Sakhawat H ^a  

^a ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER SPECIFIC SURVIVAL; CANCER SURVIVAL; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODAL POSITIVITY; LYMPH NODE BURDEN; LYMPH NODE METASTASIS; LYMPH NODE RATIO; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; ONCOLOGICAL PARAMETERS; OUTCOME ASSESSMENT; PANCREAS ADENOCARCINOMA; PANCREAS RESECTION; PANCREATICODUODENECTOMY; PROGNOSIS; RECURRENT CANCER; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM, RESIDUAL; PANCREATECTOMY; PANCREATIC NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84882450960     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/hpb.12019     Document Type: Article

References (37)

1. House MG, Gonen M, Jamagin WR, DÁngelica M, DeMatteo RP, Fong Y, et al. (2007) Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer. J Gastrointest Surg 11: 1549-1555.
2. Tseng JF, Raut CP, Lee JE, Pisters PW, Vauthey JN, Abdalla EK, et al. (2004) Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg 8: 935-949.
3. Winter JM, Cameron JL, Campbell KA, Arnold MA, Chang DC, Coleman J, et al. (2006) 1423 pancreaticoduodenctomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg 10: 1199-1210.
4. Richter A, Niedergethmann M, Sturm JW, Lorenz D, Post S, Trede M,. (2003) Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience. World J Surg 27: 324-329.
5. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. (2008) Cancer Statistics, 2008. CA Cancer J Clin 58: 71-96.
6. Sener SF, Fremgen A, Menck HR, Winchester DP,. (1999) Pancreatic cancer: a report of treatment and survival trends for 100, 313 patients diagnosed from 1985-1995, using the National Cancer database. J Am Coll Surg 189: 1-7.
7. Neoptolemos JP, Stocken DD, Dunn JA, Almond J, Beger HG, Pederzoli P, et al. (2001) Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg 234: 758-768.
8. Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K, et al. (2007) Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297: 267-277.
9. Lim JE, Chien MW, Earle CC,. (2003) Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg 237: 74-85.
10. Breslin TM, Hess KR, Harbison DB, Jean ME, Cleary KR, Dackiw AP, et al. (2001) Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. Ann Surg Oncol 8: 123-132.
11. Chen JWC, Bhandari M, Astill DS, Wilson TG, Kow L, Brooke-Smith M, et al. (2010) Predicting patient survival after pancreaticoduodenctomy for malignancy: histological criteria based on perinueral infiltration and lymphovascular invasion. HPB 12: 101-108.
12. Pawlik TM, Gleisner AL. Cameron JL, Winter JM, Assumpcao L, Lillemoe KD, et al. (2007) Prognostic relevance of lymph node ratio following pacreatiduodenctomy for pancreatic cancer. Surgery 141: 610-618.
13. The Royal College of Pathologists. (2002) Standards and Minimum Datasets for Reporting Cancers. Minimum Dataset for the Histopathological Reporting of Pancreatic, Ampulla of Vater and Bile Duct Carcinoma. London: The Royal College of Pathologists.
14. Adam IJ, Mohamdee MO, Martin IG, Scott N, Finan PJ, Johnston D, et al. (1994) Role of circumferential resection margin involvement in the local recurrence of rectal cancer. Lancet 344: 707-711.
15. Birbeck KF, Macklin CP, Tiffin NJ, Parsons W, Dixon MF, Mapstone NP, et al. (2002) Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg 235: 449-457.
16. Jamieson NB, Foulis AK, Oien KA, Going JJ, Glen P, Dickson EJ, et al. (2010) Positive mobilization margins alone do not influence survival following pancreatico-duodenctomy for pancreatic ductal adenocarcinoma. Ann Surg 251: 1003-1010.
17. Sohn TA, Yeo CJ, Cameron JL, Koniaris L, Kaushal S, Abrams RS, et al. (2000) Resected adenocarcinoma of the pancreas- 616 patients: results, outcomes, and prognostic indicators. J Gastointest Surg 4: 567-579.
18. Yeo CJ, Cameron JL, Lillemoe KD, Sitzmann JV, Hruban RH, Goodman SN, et al. (1995) Pancreaticoduodenctomy for cancer of the head of the pancreas. 201 patients. Ann Surg 221: 721-731.
19. Neoptolemos JP, Dunn JA, Stocken DD, Almond J, Link K, Beger H, et al. (2001) Adjuvant Chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomized controlled trial. Lancet 358: 1576-1585.
20. Bouvet M, Gamagami RA, Gilpin EA, Romeo O, Sasson A, Easter DW, et al. (2000) Factors influencing survival after resection for periampullary neoplasm. Am J Surg 180: 13-17.
21. Fusai G, Warnaar N, Sabin CA, Archibong S, Davidson BR,. (2008) Outcome of R1 resection in patients undergoing pancreatico-duodenctomy for pancreatic cancer. Eur J Surg Oncol 34: 1309-1315.
22. Jarufe NP, Coldham C, Mayer AD, Mirza DF, Buckels JA, Bramhall SR,. (2004) Favourable prognostic factors in a large UK experience adenocarcinoma of the head of the pancreas and periampullary region. Dig Surg 21: 202-209.718-725.; discussion 725-727.
23. Raut CP, Tseng JF, Sun CC, Wang H, Wolff RA, Crane CH, et al. (2007) Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg 246: 52-60.
24. Schmidt CM, Powell ES, Yiannoustsos CT, Howard TJ, Wiebke EA, Wiesenauer CA, et al. (2004) Pancreaticoduodenectomy: a 20-year experience in 516 patients. Arch Surg 139: 725-727.
25. Riediger H, Keck T, Wellner U, zur Hausen A, Adam U, Hopt UT, et al. (2009) The Lymph Node ratio is the strongest prognostic factor after resection of pancreatic cancer. J Gastrointest Surg 13: 1337-1344.
26. Schwarz RE, Smith DD,. (2006) Extent of lymph node retrieval and pancreatic cancer survival: information from a large US population database. Ann Surg Oncol 13: 1189-1200.
27. Bando E, Yonemura Y, Taniguchi K, Fushida S, Fujimura T, Miwa K,. (2002) Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol 9: 775-784.
28. Berger AC, Sigurdson ER, LeVoyer T, Hanlon A, Mayer RJ, Macdonald JS, et al. (2005) Colon Cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol 23: 8706-8712.
29. Le Voyer TE, Sigurdson ER, Hanlon AL, Mayer RJ, Macdonald JS, Catalano PJ, et al. (2003) Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol 21: 2912-2919.
30. Bhatti I, Peacock O, Awan AK, Semeraro D, Larvin M, Hall RI,. (2010) Lymph node ratio versus number of affected lymph nodes as predictors of survival for resected pancreatic adenocarcinoma. World J Surg 34: 768-775.
31. Katz MHG, Want H, Fleming J, Sun CC, Hwang RF, Wolff RA, et al. (2009) Long-Term survival after multidisciplinary management of resected pancreatic adenocarcinoma. Ann Surg Oncol 16: 836-847.
32. Slidell MB, Chang DC, Cameron JL, Wolfgang C, Herman JM, Schulick RD, et al. (2008) Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis. Ann Surg Oncol 15: 165-174.
33. Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Nakashima A, et al. (2010) Number of metastatic lymph nodes, but not lymph node ratio, is an independent prognostic factor after resection of pancreatic carcinoma. J Am Coll Surg 211: 196-204.
34. Evans DB, Farnell MB, Lillemoe KD, Vollmer C Jr, Strasberg SM, Schulick RD,. (2009) Surgical Treatment of Resectable and Borderline Resectable Pancreas Cancer: expert consensus statement. Ann Surg Oncol 16: 1736-1744.
35. Campbell F, Smith RA, Whelan P, Sutton R, Raraty M, Neoptolemus JP, et al. (2009) Classification of R1 resections for pancreatic cancer: the prognostic relevance of tumour involvement within 1mm of a resection margin. Histopathology 55: 277-283.
36. Menon KV, Gomez D, Smith AM, Anthony A, Verbeke CS,. (2009) Impact of margin status on survival following pancreatoduodenectomy for cancer: the Leeds Pathology Protocol (LEEPP). HPB 11: 18-24.
37. Esposito I, Kleeff J, Bergmann F, Reiser C, Herpel E, Friess H, et al. (2008) Most pancreatic cancer resections are R1 resections. Ann Surg Oncol 15: 1651-1660.